Apyx Medical (APYX) Competitors

Apyx Medical (NASDAQ:APYX) and Beyond Air (NASDAQ:XAIR) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, dividends, institutional ownership, community ranking, analyst recommendations, profitability, earnings and media sentiment.

Does the media refer more to APYX or XAIR?

In the previous week, Apyx Medical and Apyx Medical both had 1 articles in the media. Beyond Air's average media sentiment score of 1.29 beat Apyx Medical's score of 0.00 indicating that Beyond Air is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Apyx Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Beyond Air	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has better valuation & earnings, APYX or XAIR?

Apyx Medical has higher revenue and earnings than Beyond Air. Apyx Medical is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Apyx Medical	$52.35M	0.91	-$18.71M	-$0.54	-2.56
Beyond Air	N/A	N/A	-$55.82M	-$2.13	-0.56

Which has more risk and volatility, APYX or XAIR?

Apyx Medical has a beta of 1.09, suggesting that its share price is 9% more volatile than the S&P 500. Comparatively, Beyond Air has a beta of -0.18, suggesting that its share price is 118% less volatile than the S&P 500.

Is APYX or XAIR more profitable?

Beyond Air has a net margin of 0.00% compared to Apyx Medical's net margin of -35.75%. Apyx Medical's return on equity of -54.90% beat Beyond Air's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Apyx Medical	-35.75%	-54.90%	-28.41%
Beyond Air	N/A	-199.90%	-106.00%

Do analysts rate APYX or XAIR?

Apyx Medical presently has a consensus target price of $6.17, suggesting a potential upside of 346.86%. Beyond Air has a consensus target price of $11.25, suggesting a potential upside of 845.38%. Given Beyond Air's higher possible upside, analysts plainly believe Beyond Air is more favorable than Apyx Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Apyx Medical	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
Beyond Air	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Do insiders & institutionals believe in APYX or XAIR?

55.3% of Apyx Medical shares are held by institutional investors. Comparatively, 31.5% of Beyond Air shares are held by institutional investors. 13.1% of Apyx Medical shares are held by company insiders. Comparatively, 19.0% of Beyond Air shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Does the MarketBeat Community believe in APYX or XAIR?

Apyx Medical received 34 more outperform votes than Beyond Air when rated by MarketBeat users. However, 68.25% of users gave Beyond Air an outperform vote while only 61.60% of users gave Apyx Medical an outperform vote.

Company	Underperform	Outperform
Apyx Medical	Outperform Votes 77 61.60%	Underperform Votes 48 38.40%
Beyond Air	Outperform Votes 43 68.25%	Underperform Votes 20 31.75%

Summary

Apyx Medical beats Beyond Air on 8 of the 15 factors compared between the two stocks.